CCL2 and inflammatory bowel disease: For example, in inflammatory colitis, the upregulation of monocyte chemoattractant protein-1 (MCP-1), an inflammatory chemokine, has been shown to be in higher concentrations in tumors versus normal mucosa and has also been the site of new targeted therapies to reduce cancer risk in inflammatory bowel disease [21,22].